House Bill 190

Actions | Amendments
Last Action 04/18/24: signed by Governor
Title AN ACT relating to pharmacy benefits.
Bill Documents Current/Final
Introduced
Fiscal Impact Statements Actuarial Analysis
Health Mandate
Local Mandate
Additional Fiscal Impact Statements Exist
Bill Request Number 898
Sponsor S. Sharp
Summary of Original Version Amend KRS 304.17A-164 to prohibit insurers, pharmacy benefit managers, and other pharmacy benefit administrators from requiring or incentivizing the use of a mail-order pharmaceutical distributor; amend KRS 304.17C-125, 304.38A-115, 18A.225, and 164.2871 to apply provisions of amended KRS 304.17A-164 to limited health service benefit plans, including limited health service contracts, limited health service organizations, the state employee health plan, and postsecondary educational institution self-insured group health plans; repeal 304.38A-120, relating to assignment of certain benefits under limited health service organization plans, to consolidate like provisions; make technical corrections; EFFECTIVE January 1, 2025.
Index Headings of Original Version Local Mandate - Prescription drugs, distribution, requirements
Drugs and Medicines - Prescription drugs, distribution, insurance practices
Education, Higher - Health plan, prescriptions drugs, distribution, requirements
Effective Dates, Delayed - Prescription drugs, distribution, insurance practices, January 1, 2025
Insurance, Health - Prescription drugs, distribution, requirements
Pharmacists - Prescription drugs, distribution, insurance practices
State Employees - Health plan, prescription drugs, distribution, requirements
Technical Corrections - Prescription drugs, distribution, insurance practices
Health Benefit Mandate - Prescription drugs, distribution, requirements
Actuarial Analysis - Prescription drugs, distribution, insurance practices
Jump to Proposed Amendments House Committee Substitute 1 with Fiscal Impact Statements
Senate Committee Substitute 1
Votes Vote History

Actions

Top | Amendments
01/08/24
  • introduced in House
  • to Committee on Committees (H)
02/15/24
  • to Health Services (H)
03/07/24
  • reported favorably, 1st reading, to Calendar with Committee Substitute (1)
03/08/24
  • 2nd reading, to Rules
  • posted for passage in the Regular Orders of the Day for Monday, March 11, 2024
03/12/24
  • 3rd reading, passed 96-0 with Committee Substitute (1)
03/13/24
  • received in Senate
  • to Committee on Committees (S)
03/28/24
  • taken from Committee on Committees (S)
  • 1st reading
  • returned to Committee on Committees (S)
04/12/24
  • to Banking & Insurance (S)
  • taken from Banking & Insurance (S)
  • 2nd reading
  • returned to Banking & Insurance (S)
04/15/24
  • reported favorably, to Rules with Committee Substitute (1) as a consent bill
  • posted for passage in the Consent Orders of the Day for Monday, April 15, 2024
  • 3rd reading, passed 38-0 with Committee Substitute (1)
  • received in House
  • to Rules (H)
  • posted for passage for concurrence in Senate Committee Substitute (1)
  • House concurred in Senate amendment Committee Substitute (1)
  • passed 92-0
  • enrolled, signed by Speaker of the House
  • enrolled, signed by President of the Senate
  • delivered to Governor
04/18/24
  • signed by Governor

Proposed Amendments

Top | Actions
Amendment House Committee Substitute 1
Fiscal Impact Statements Actuarial Analysis to House Committee Substitute 1
Health Mandate to House Committee Substitute 1
Local Mandate to House Committee Substitute 1
Summary Retain original provisions, except amend definition of "insurer" to make technical amendment; add definition of "mail-order pharmaceutical distributor"; delete prohibition on requiring or incentivizing use of a mail-order pharmaceutical distributor; prohibit imposing greater or more restrictive requirements for use of a retail pharmacy to access a drug in certain circumstances.
Index Headings Local Mandate - Prescription drugs, distribution, requirements
Actuarial Analysis - Prescription drugs, distribution, insurance practices
Health Benefit Mandate - Prescription drugs, distribution, insurance practices
Drugs and Medicines - Prescription drugs, distribution, insurance practices
Insurance, Health - Prescription drugs, distribution, requirements
Pharmacists - Prescription drugs, distribution, insurance practices

Amendment Senate Committee Substitute 1
Summary Delete original provisions; amend 2024 Ky. Acts. ch. 104, sec. 3 (2024 RS SB 188/GA, sec. 3) to define "national average drug acquisition cost"; temporarily exempt retail chain pharmacies from minimum drug reimbursement requirement; make technical amendment; EFFECTIVE January 1, 2025.
Index Headings Drugs and Medicines - Minimum reimbursement, prescription drugs and other services
Effective Dates, Delayed - Pharmacy provider contracts, minimum reimbursement, January 1, 2025
Insurance, Health - Provider contracts, minimum reimbursement, prescription drugs and other services
Pharmacists - Minimum reimbursement, prescription drugs and other services
Actuarial Analysis - Minimum reimbursement, prescription drugs and other services
Health Benefit Mandate - Minimum reimbursement, prescription drugs and other services
Local Mandate - Minimum reimbursement, prescription drugs and other services
Technical Corrections - HB 190/SCS 1

Last updated: 4/22/2024 3:57 PM (EDT)